97色偷偷色噜噜狠狠爱网站-男女啪啪做爰高潮无遮挡-欧美精品一区二区三区在线-永久免费的av在线电影网无码-级r片内射在线视频播放

Home>About Livzon>Company Profile

Profile of Zhuhai Livzon Diagnostics Inc.
Zhuhai Livzon Diagnostics Inc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of the listed company, Livzon Pharmaceutical Group (A-share and H-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. Livzon Diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in China, a national high-tech enterprise.

Livzon Diagnostics has established many technical platforms such as Enzyme-linked Immunoassay, lateral flow chromatography, Microorganisms testing, Molecular testing, Multiple-detection Immunoassay, Single-test Chemiluminescence immunoassay, Mast Cell Degranulation Test for Allergy, etc. Meanwhile, Livzon Diagnostics also has fully automatic equipment development capability. The products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. Therefore, Livzon Diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

Zhuhai Livzon Diagnostics Inc.  has equipped with its industrialization base for Research and Development, Production and Office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for Research and Development, which attracts professional elite talents from Laboratory Science, Biological engineering and many other fields. Zhuhai Livzon Diagnostics Inc. owns 5 Research and Development teams spread in 3 Research and Development centers, which located in Zhuhai, Shanghai and Suzhou city. The total Research and Development personnel accounted for nearly 20% , meanwhile the annual Research and Development investment reaches more than 10% of Sales Revenue. Beside its independent Research and Development, Zhuhai Livzon Diagnostics Inc. has established long-term successful cooperation with many first-class International Biomedical Enterprises such as Fujirebro from Japan, Siemens in Germany, and MP company (USA), which has enhanced its comprehensive service capabilities. Zhuhai Livzon Diagnostics Inc. has won the title of honor as "National High-tech Enterprises", "In vitro diagnostic Engineering Technology Research Center of Guangdong Province ", "Guangdong Provincial Enterprise Technology Center", "Innovative Enterprises of Guangdong Province " and the national "Post-doctoral Research Station". With a complete quality management system in production, Zhuhai Livzon Diagnostics Inc. has well achieved the national GMP certification, GSP certification and ISO13485/ISO9001 certification.
Livzon Overview
3
R&D centers
5
R&D teams
20%
scientific research personnel
50%
personnel with master degree
6000
R&D land area (m2)
作為中國IVD行業的先行者,麗珠試劑服務產品涵蓋了傳染性疾病、呼吸道感染、腫瘤標志物檢測、藥物濃度監測、自身免疫、過敏原檢測及血液安全等眾多領域,在呼吸道感染、傳染性疾病、藥物濃度監測等領域的市場占有率處于國內領先地位,多項產品市場占有率高達50%-90%。在2019年底中國爆發新型冠狀病毒的第一時間,麗珠試劑便投入研發,迅速研制出新型冠狀病毒(2019-nCoV)IgM / IgG抗體檢測試劑盒(膠體金法)產品,并獲證上市,助力國內外疫情防控。
  • 5.jpg

  • 6.jpg

Livzon Diagnostics Technology Theme Exhibition Hall
Focus on disease research · Create new detection technology

主站蜘蛛池模板: 少妇厨房愉情理伦bd在线观看 | 亚洲成av人的天堂在线观看| 苍井空张开腿实干12次| 久久国产精品成人片免费| 国产欧美日韩精品丝袜高跟鞋| 无遮挡又爽又刺激的视频| 亚洲加勒比无码一区二区| 亚洲高清专区日韩精品| 国产精品丝袜亚洲熟女| 国产av无码专区亚洲版综合| 男人添女人下部高潮全视频| 欧美亚洲国产一区二区三区| 国产日韩精品中文字无码| 精品国模一区二区三区| 无码少妇一区二区| 日产电影一区二区三区| 久久狠狠色噜噜狠狠狠狠97| 国产精品久人妻精品老妇| 欧美内射rape视频| 中文幕无线码中文字夫妻| 国产在线国偷精品免费看| 初尝黑人巨砲波多野结衣| 人人妻人人澡人人爽欧美一区双| 国产人妻777人伦精品hd| 18禁黄网站男男禁片免费观看| 欧美日韩不卡高清在线看| 国产精品亚洲精品日韩已方| 国产女人好紧好爽| 亚洲情a成黄在线观看动漫尤物 | 女性女同性aⅴ免费观女性恋| 澳门永久av免费网站| 国语精品一区二区三区| av永久天堂一区二区三区香港| 55夜色66夜色国产精品视频| 国产97人人超碰caoprom三级| 久99久热只有精品国产女同| 熟女人妇交换俱乐部| 中文字幕一卡二卡三卡| 狠狠色丁香婷婷久久综合五月| 久久无码免费的a毛片大全| 亚洲精品一区国产欧美 |